CLGN

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company developing tissue-repair products based on its proprietary plant-derived recombinant human collagen (rhCollagen) technology. Headquartered in Rehovot, Israel, the company produces Type I collagen using genetically engineered tobacco plants, creating a non-animal, non-immunogenic alternative to traditional collagen sources. CollPlant's BioInk products are used in 3D bioprinting for organ and tissue regeneration, while its dermal and soft tissue fillers target the aesthetic medicine market. The company partners with medical device manufacturers and research institutions to advance its collagen platform across multiple therapeutic applications.